VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FGEN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FGENFibroGen, Inc.
$7.50$585M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFGENQuarterly Financials

FibroGen, Inc. (FGEN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

FibroGen, Inc. (FGEN) quarterly income statement — complete revenue, gross profit & net income history

FGEN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22
Sales/Revenue1.08M1.35M2.74M-123.26M46.33M998K25.36M27.14M40.13M44.32M36.16M34.37M
Revenue Growth %-97.68%35.07%-89.2%-554.18%15.45%-97.75%-29.86%-21.03%155.06%48.69%-40.55%107.74%
Cost of Goods Sold-58K85K252K-20.67M5.29M32.5M57.83M5.41M4.24M5.71M3.49M4.92M
COGS % of Revenue-5.39%6.31%9.2%16.77%11.43%3256.51%228.01%19.92%10.57%12.88%9.65%14.33%
Gross Profit1.13M1.26M2.49M-102.59M41.04M-31.5M-32.47M21.73M35.89M38.61M32.67M29.44M
Gross Margin %105.39%93.69%90.8%83.23%88.57%-3156.51%-128.01%80.08%89.43%87.12%90.35%85.67%
Gross Profit Growth %-97.24%104.01%107.66%-572.09%14.34%-181.59%-199.38%-26.19%214.09%67.9%200.74%171.73%
Operating Expenses6.54M13.31M17.41M-10.93M57.82M14.91M16.71M75.93M99.37M126.66M108.76M95.59M
OpEx % of Revenue608.27%987.76%635.52%8.87%124.78%1493.59%65.9%279.78%247.6%285.79%300.77%278.16%
Selling, General & Admin5.29M7.06M8.11M-13.32M17.55M0024.22M25.57M31.18M34.27M33.97M
SG&A % of Revenue492.1%523.52%295.95%10.81%37.89%--89.26%63.72%70.36%94.78%98.83%
Research & Development1.21M5.87M9.18M1.49M21.71M32.36M36.49M51.7M61.19M95.48M74.49M61.63M
R&D % of Revenue112.36%435.09%334.98%-1.21%46.85%3242.49%143.86%190.52%152.47%215.43%205.98%179.32%
Other Operating Expenses41K393K126K900K1000K-1000K-1000K01000K000
Operating Income-5.41M-12.05M-14.92M-91.66M-16.78M-46.41M-49.18M-54.2M-63.48M-88.05M-76.09M-66.15M
Operating Margin %-502.88%-894.07%-544.72%74.36%-36.21%-4650.1%-193.9%-199.7%-158.18%-198.67%-210.42%-192.49%
Operating Income Growth %67.75%74.03%69.66%-69.12%73.57%47.29%35.36%18.07%32.22%-12.56%-20.79%51.09%
EBITDA-5.22M-11.83M-14.59M-91.3M-16.04M-45.63M-48.36M-52.32M-61.1M-85.34M-73.13M-63.46M
EBITDA Margin %-485.04%-877.67%-532.79%74.08%-34.62%-4571.84%-190.67%-192.79%-152.25%-192.55%-202.22%-184.66%
EBITDA Growth %67.46%74.07%69.83%-74.51%73.75%46.53%33.86%17.56%32.84%-12.92%-21.05%52.16%
D&A (Non-Cash Add-back)192K221K327K352K739K781K820K1.88M2.38M2.71M2.96M2.69M
EBIT-11.06M-11.77M-14.51M-91.45M-12.98M-46.41M-49.18M-51.7M-59.19M-85.4M-75.06M-65.23M
Net Interest Income-2.08M-1.72M-1.84M204K-1.19M-968K143K-2.57M-726K-417K-1.34M-195K
Interest Income0286K413K204K3.8M900K2.23M2.5M4.3M2.65M1.04M924K
Interest Expense2.08M2.01M2.26M04.99M1.87M2.09M5.07M5.02M3.07M2.37M1.12M
Other Income/Expense-7.74M-1.72M-1.84M4.07M-294K-968K143K-1.96M-49K133K-540K85K
Pretax Income-13.15M-13.78M-16.76M-87.59M-17.07M-47.38M-49.04M-56.15M-63.53M-87.92M-76.63M-66.07M
Pretax Margin %-1221.75%-1021.88%-612.05%71.06%-36.85%-4747.09%-193.34%-206.91%-158.3%-198.37%-211.92%-192.24%
Income Tax0-92K2K-52K12K-281K7K80K84K-235K74K108K
Effective Tax Rate %0%0.67%-0.01%0.06%-0.07%0.59%-0.01%-0.14%-0.13%0.27%-0.1%-0.16%
Net Income200.64M-7.6M4.64M17.98M-17.08M-15.54M-32.93M-56.23M-63.62M-87.68M-76.7M-66.17M
Net Margin %18646.47%-564.02%169.37%-14.59%-36.87%-1557.52%-129.84%-207.21%-158.51%-197.84%-212.12%-192.55%
Net Income Growth %1274.41%51.09%114.09%131.98%73.14%82.27%57.07%15.03%30.59%-20.73%-21.36%50.64%
Net Income (Continuing)-13.15M-13.68M-16.77M-87.54M-17.08M-47.09M-49.05M-56.23M-63.62M-87.68M-76.7M-66.17M
Discontinued Operations1000K1000K1000K001000K1000K00000
Minority Interest34.51M41.97M41.97M41.97M41.97M41.97M41.97M41.97M41.97M41.97M19.97M19.97M
EPS (Diluted)49.61-1.880.054.50-4.25-3.89-0.33-0.57-0.65-0.90-0.81-0.70
EPS Growth %1267.29%51.67%115.15%889.47%-553.85%-332.22%59.26%18.57%33.67%-15.38%-19.12%51.72%
EPS (Basic)49.61-1.880.054.50-4.25-3.89-0.33-0.57-0.65-0.90-0.81-0.70
Diluted Shares Outstanding4.04M4.04M100.95M4.03M4.02M3.99M98.98M98.5M98.25M97.73M94.69M94.03M
Basic Shares Outstanding4.04M4.04M100.95M4.03M4.02M3.99M98.98M98.5M98.25M97.73M94.69M94.03M
Dividend Payout Ratio------------